a lot happening, page-4

I agree with you that things seem to be moving slowly and I believe it is because things of significants are happening on three continents that MR resigned his post as a director ,so he could concentrate on the trials.After all that is what determins the value of the treatment and the company.
From my understanding each individual in the trials must have the treatment individually designed.I have assumed this is what has taken the time,however I could be wrong.I do think an explanation from the company would be reassuring.
My point about Europe was it presented another front and more for MR to do
All the best